In non-small cell lung cancer (NSCLC), the ability of canagliflozin to induce apoptosis by a mechanism independent of SGLT-2 inhibition and cellular glucose influx was demonstrated [158]. The gene discussed is SLC5A2; the disease is non-small cell lung carcinoma.